Peter van Veelen

40PUBLICATIONS
247CO-AUTHORS
Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Oct 16, 2026
Chemogenetic ubiquitin E1 inhibitor TAK-243 CRISPR screen uncovers HAPSTR1/HUWE1 axis in chromatin proteostasis and cell cycle control.

|Aug 24, 2026
Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

|Apr 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire.

Hannes Kehm, Stefan Zens, Daniel Baumann

|Mar 05, 2026
Site-specific profiling of structure and function of Igµ B cell receptor glycans.

M D Holborough-Kerkvliet, L Hafkenscheid, S Kroos

|Jan 19, 2026
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Floortje J van Haften, Tetje C van der Sluis, Hanna S Hepp

|Dec 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

Nadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong

Pageof 7

Frequent Collaborators

7 joint publications

Paul J Hensbergen

6 joint publications

Aysegul Sapmaz

6 joint publications

Mirjam H M Heemskerk

6 joint publications

Arnoud H de Ru